Latest News & Features
Americas
The Patent Trial and Appeal Board has rejected three inter partes reviews filed by Kyle Bass’s organisation the Coalition for Affordable Drugs. 11 March 2016
Americas
The US Patent and Trademark Office has opened proceedings to determine who owns the rights to the CRISPR/Cas9 technology. 11 March 2016
Americas
The US Food and Drug Administration has appointed Stephen Ostroff to deputy commissioner for food and veterinary medicine. 10 March 2016
Big Pharma
Pharmaceutical company AstraZeneca agreed a deal with ProStrakan Group centring on the rights to the Moventig (naloxegol) drug in Europe. 9 March 2016
Africa
The UK Intellectual Property Office has issued a favourable decision on an SPC for an “innovative” combination product. David Carling and Michael Pears of Potter Clarkson explain the reasoning and examine its implications. 9 March 2016
Big Pharma
In February the English High Court ruled that Actavis had not indirectly infringed a patent owned by Eli Lilly directed to cancer drug Alimta. David Read of Bartle Read reports. 8 March 2016
Biotechnology
The English High Court has allowed Japan-based drug maker Fujifilm Kyowa Kirin Biologics to amend some of its arguments in a patent dispute surrounding AbbVie’s arthritis drug Humira. 8 March 2016
Americas
Pharmaceutical company Teva has bought Mexico-based Representaciones e Investigaciones Médicas, in a deal totalling $2.3 billion. 8 March 2016
Americas
The International Trade Commission has invalidated two patents owned by Jawbone because they cover “ineligible subject matter”, dealing a blow to the wearable fitness company in its legal battle with rival Fitbit. 7 March 2016
Americas
A US court has brought to a close a patent lawsuit that cancer care company Helsinn Healthcare filed against Teva after determining that Helsinn did not trigger the on-sale bar provision when marketing its anti-cancer drug Aloxi (palonosetron). 4 March 2016